Christos Hatzis
Christos Hatzis
Adjunct Associate Professor of Medicine, Yale School of Medicine, Yale Cancer Center
Verified email at yale.edu - Homepage
Title
Cited by
Cited by
Year
Measurement of residual breast cancer burden to predict survival after neoadjuvant chemotherapy
WF Symmans, F Peintinger, C Hatzis, R Rajan, H Kuerer, V Valero, ...
Journal of Clinical Oncology 25 (28), 4414-4422, 2007
10102007
The MicroArray Quality Control (MAQC)-II study of common practices for the development and validation of microarray-based predictive models
MaQC Consortium
Nature biotechnology 28 (8), 827, 2010
6652010
A genomic predictor of response and survival following taxane-anthracycline chemotherapy for invasive breast cancer
C Hatzis, L Pusztai, V Valero, DJ Booser, L Esserman, A Lluch, T Vidaurre, ...
Jama 305 (18), 1873-1881, 2011
4522011
Commercialized multigene predictors of clinical outcome for breast cancer.
JS Ross, C Hatzis, WF Symmans, L Pusztai, GN Hortobagyi
Oncologist 13 (5), 2008
2712008
Genomic index of sensitivity to endocrine therapy for breast cancer
WF Symmans, C Hatzis, C Sotiriou, F Andre, F Peintinger, P Regitnig, ...
Journal of clinical oncology 28 (27), 4111, 2010
2382010
Multigene prognostic tests in breast cancer: past, present, future
B Győrffy, C Hatzis, T Sanft, E Hofstatter, B Aktas, L Pusztai
Breast cancer research 17 (1), 1-7, 2015
2092015
Long-term prognostic risk after neoadjuvant chemotherapy associated with residual cancer burden and breast cancer subtype
WF Symmans, C Wei, R Gould, X Yu, Y Zhang, M Liu, A Walls, ...
Journal of Clinical Oncology 35 (10), 1049, 2017
2062017
Effect of training-sample size and classification difficulty on the accuracy of genomic predictors
V Popovici, W Chen, BD Gallas, C Hatzis, W Shi, FW Samuelson, ...
Breast Cancer Research 12 (1), R5, 2010
1882010
Genomic grade index is associated with response to chemotherapy in patients with breast cancer
C Liedtke, C Hatzis, WF Symmans, C Desmedt, B Haibe-Kains, V Valero, ...
Journal of clinical oncology 27 (19), 3185, 2009
1882009
Common contaminants in next-generation sequencing that hinder discovery of low-abundance microbes
M Laurence, C Hatzis, DE Brash
PloS one 9 (5), e97876, 2014
1872014
Estrogen receptor (ER) mRNA and ER-related gene expression in breast cancers that are 1% to 10% ER-positive by immunohistochemistry
T Iwamoto, D Booser, V Valero, JL Murray, K Koenig, FJ Esteva, NT Ueno, ...
J Clin Oncol 30 (7), 729-734, 2012
1832012
Molecular anatomy of breast cancer stroma and its prognostic value in estrogen receptor-positive and-negative cancers
G Bianchini, Y Qi, RH Alvarez, T Iwamoto, C Coutant, NK Ibrahim, ...
J Clin Oncol 28 (28), 4316-4323, 2010
1782010
KDD Cup 2001 report
J Cheng, C Hatzis, H Hayashi, MA Krogel, S Morishita, D Page, J Sese
ACM SIGKDD Explorations Newsletter 3 (2), 47-64, 2002
1512002
Microtubule-associated protein-tau is a bifunctional predictor of endocrine sensitivity and chemotherapy resistance in estrogen receptor–positive breast cancer
F Andre, C Hatzis, K Anderson, C Sotiriou, C Mazouni, J Mejia, B Wang, ...
Clinical Cancer Research 13 (7), 2061-2067, 2007
1432007
Identification of inhibitory components toxic toward Zymomonas mobilis CP4 (pZB5) xylose fermentation
TD Ranatunga, J Jervis, RF Helm, JD McMillan, C Hatzis
Applied biochemistry and biotechnology 67 (3), 185, 1997
1421997
Hydrolysis and fractionation of lignocellulosic biomass
RW Torget, N Padukone, C Hatzis, CE Wyman
US Patent 6,022,419, 2000
1372000
Biochemical engineering analysis of critical process factors in the biomass‐to‐ethanol technology
GP Philippidis, C Hatzis
Biotechnology progress 13 (3), 222-231, 1997
951997
Effects of tissue handling on RNA integrity and microarray measurements from resected breast cancers
C Hatzis, H Sun, H Yao, RE Hubbard, F Meric-Bernstam, GV Babiera, ...
Journal of the National Cancer Institute 103 (24), 1871-1883, 2011
912011
Optimization of reverse-flow, two-temperature, dilute-acid pretreatment to enhance biomass conversion to ethanol
R Torget, C Hatzis, TK Hayward, TA Hsu, G Philippidis
Seventeenth Symposium on Biotechnology for Fuels and Chemicals, 85-101, 1996
871996
Enhancing reproducibility in cancer drug screening: how do we move forward?
C Hatzis, PL Bedard, NJ Birkbak, AH Beck, HJWL Aerts, DF Stern, L Shi, ...
Cancer research 74 (15), 4016-4023, 2014
802014
The system can't perform the operation now. Try again later.
Articles 1–20